Figure 1
From: Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
Mean plasma concentration–time curve of sagopilone after single intravenous infusion of 16 mg m−2 sagopilone over 3 h (N=9–10).
Figure 1 | British Journal of Cancer
